phenytoin has been researched along with Pseudohypoparathyroidism in 2 studies
Pseudohypoparathyroidism: A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robinson, PB | 1 |
| Harris, M | 2 |
| Harvey, W | 1 |
| Papadogeorgakis, N | 1 |
| Goldhaber, P | 1 |
2 other studies available for phenytoin and Pseudohypoparathyroidism
| Article | Year |
|---|---|
Reduced bone growth in rats treated with anticonvulsant drugs: a type II pseudohypoparathyroidism?
Topics: Animals; Anticonvulsants; Bone and Bones; Bone Development; Calcium; Female; Male; Parathyroid Gland | 1982 |
Root abnormalities in epileptics and the inhibition of parathyroid hormone induced bone resorption by diphenyl hydantoin in tissue culture.
Topics: Adult; Animals; Bone Resorption; Culture Techniques; Epilepsy; Humans; Mice; Parathyroid Hormone; Pe | 1974 |